Search

everythinglearnresearchcommunity

for

Search:↓

Both injectable contraceptives lower testosterone and SHBG levels, with NET-EN having a greater effect than DMPA-IM.

Vitamin D may help improve hormone levels in women with PCOS.

Vitamin D deficiency is linked to a higher chance of metabolic syndrome in women with PCOS.

Many women with polycystic ovary syndrome have normal blood sugar, but some may have higher blood sugar levels or diabetes, especially if they are older, overweight, and have certain hormone levels.

Clinical signs of hyperandrogenism are related to female pattern hair loss severity, but biochemical markers are not.

Phoenixin levels are higher in PCOS patients and may help in diagnosis.

The levonorgestrel implant increases free testosterone and lowers SHBG more than DMPA-IM and the copper IUD.

Pregnant women with PCOS have higher levels of Neurokinin B in the placenta, especially with female babies.

Using stem cells from hair follicles to treat female hair loss is safe and effective after six months.

Hormonal imbalances are important in the development of male pattern baldness.

Genes and epigenetic changes are important in the development of Polycystic Ovary Syndrome.

Choosing the right starting dose of Clomiphene Citrate for ovulation induction in PCOS women is challenging; higher BMI and hormone levels may indicate resistance to the standard dose.

Women with Polycystic Ovary Syndrome are more likely to have Non-Alcoholic Fatty Pancreas Disease, which is associated with older age, metabolic syndrome, insulin resistance, and high male hormone levels.

Lipid Accumulation Product and Free Androgens Index are effective for assessing fatty liver disease risk in women with Polycystic Ovary Syndrome.

People with androgenetic alopecia, both men and women, are more likely to develop heart diseases in the future.

Reducing iron levels didn't improve heart health or metabolism in women with certain ovarian issues.

Postmenopausal women with hyperandrogenism didn't have better metabolic health even after their testosterone levels became normal.

Mild thyroid issues don't affect the metabolism and hormones of women with PCOS.

Weight loss and metformin don't significantly change vaspin levels in women with PCOS.

Dutasteride and finasteride may reduce sperm count and volume but don't affect movement or shape; effects are reversible after stopping.

Combining liraglutide and metformin helps obese women with PCOS who didn't lose weight on metformin alone to lose more weight.

Insulin-lowering medications show promise for PCOS symptoms but can't be the main treatment yet due to limited long-term research.

ChatGPT-5 can pass the endocrinology exam but isn't fully reliable for clinical decisions yet.

Surgery to lower high testosterone in postmenopausal women with certain ovarian tumors doesn't significantly affect their metabolism.

17α-estradiol is a safe estrogen that might protect the brain and doesn't cause feminization, needing more research for treating brain diseases.

Women with PCOS have similar levels of certain proteins compared to women without PCOS, and these proteins don't independently cause PCOS.

The study found that women with PCOS have more and larger ovarian follicles and differences in ovarian structure, but these features alone can't always diagnose PCOS.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

Blood hormone levels don't accurately show brain hormone levels in males.

Acne can't be cured but can be managed with treatments like benzoyl peroxide and diet changes; it's costly and can lead to scarring and mental health issues.